Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 3808

Sort by

Sort Order Select

Journal Articles

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML

Harrison Silva, Grace Martin, Filippo Birocchi, Marc Wehrli, Michael C Kann, Valentina M Supper, Aiyana Parker, Charlotte E Graham, Alexandra Grace Bratt, Amanda A Bouffard, Hannah Donner, Giulia Escobar, Hana N Takei, Alexander Armstrong, Sadie Goncalves, Trisha R Berger, Bryan D. Choi, Marcela V Maus, Mark B Leick

Blood blood.2023023210.

https://doi.org/10.1182/blood.2023023210

Published: 2024

Includes: Supplemental data

Journal Articles

Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia

Jihong Ma, Zhaohui Wang, Danielle Mintzlaff, Huiping Zhang, Rashmi Ramakrishna, Eduardo Davila, Matthew T. Witkowski, M Scott Lucia, Marc S. Schwartz, Elizabeth A. Pomfret, David W. Mathes, Zhirui Wang

Blood blood.2024025277.

https://doi.org/10.1182/blood.2024025277

Published: 2024

Includes: Supplemental data

Journal Articles

Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma

Blood (2024) 144 (20): 2121–2135.

https://doi.org/10.1182/blood.2024024590

Published: 2024

Includes: Supplemental data

Journal Articles

Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy

Xavier Deschênes-Simard, Bianca D. Santomasso, Parastoo B. Dahi

Blood (2024) 144 (20): 2083–2094.

https://doi.org/10.1182/blood.2024025679

Published: 2024

Journal Articles

New insights into the biology of T-cell lymphomas

Javeed Iqbal, Giorgio Inghirami, Wing C. Chan

Blood (2024) 144 (18): 1873–1886.

https://doi.org/10.1182/blood.2023021787

Published: 2024

Includes: Supplemental data

Journal Articles

Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma

Jing Nie, Chunmeng Wang, Liangtao Zheng, Yang Liu, Chengcheng Wang, Yixin Chang, Yudi Hu, Bing Guo, Yuting Pan, Qingming Yang, Xueda Hu, Weidong Han

Blood (2024) 144 (18): 1936–1950.

https://doi.org/10.1182/blood.2024024487

Published: 2024

Includes: Supplemental data

Journal Articles

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

Blood blood.2024025987.

https://doi.org/10.1182/blood.2024025987

Published: 2024

Includes: Supplemental data

Journal Articles

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

Blood blood.2024025366.

https://doi.org/10.1182/blood.2024025366

Published: 2024

Includes: Supplemental data

Journal Articles

Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression

Tianyi Zhang, Yi-Fang Wang, Alex Montoya, Ilinca Patrascan, Nehir Nebioglu, Husayn A Pallikonda, Radina Georgieva, James WD King, Holger B Kramer, Pavel V Shliaha, David S. Rueda, Matthias Merkenschlager

Blood blood.2024024787.

https://doi.org/10.1182/blood.2024024787

Published: 2024

Includes: Supplemental data

Journal Articles

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

Blood (2024) 144 (16): 1747–1751.

https://doi.org/10.1182/blood.2024024351

Published: 2024

Includes: Supplemental data

Journal Articles

A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia

Blood (2024) 144 (16): 1689–1698.

https://doi.org/10.1182/blood.2024024952

Published: 2024

Includes: Supplemental data

Journal Articles

Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series

Blood (2024) 144 (16): 1699–1704.

https://doi.org/10.1182/blood.2024024524

Published: 2024

Includes: Supplemental data

Journal Articles

T-Cell Lymphomas in Recipients of CAR-T Cells: Assessing Risks and Causalities

Jingqiong Hu, Cynthia E. Dunbar

Blood blood.2024025828.

https://doi.org/10.1182/blood.2024025828

Published: 2024

Journal Articles

Mitigation of checkpoint inhibitor–induced autoimmune hemolytic anemia through modulation of purinergic signaling

Flavia Dei Zotti, Annie Qiu, Vivette D. D’Agati, Shwatina Jagnarine, Emmalene Kyritsis, Anabel Miller, Maria Tredicine, Daysha Fliginger, Elizabeth F. Stone, Sandhya Panch, Krystalyn E. Hudson

Blood (2024) 144 (15): 1581–1594.

https://doi.org/10.1182/blood.2024024230

Published: 2024

Includes: Supplemental data

Journal Articles

The intestinal microbiota and cellular therapy: implications for impact and mechanisms

Jiayi Xie, Melody Smith

Blood (2024) 144 (15): 1557–1569.

https://doi.org/10.1182/blood.2024024219

Published: 2024

Journal Articles

Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases

Silvia Lucena Lage, Ramya Ramaswami, Joseph M. Rocco, Adam Rupert, David A. Davis, Kathryn Lurain, Maura Manion, Denise Whitby, Robert Yarchoan, Irini Sereti

Blood (2024) 144 (14): 1496–1507.

https://doi.org/10.1182/blood.2024024144

Published: 2024

Includes: Supplemental data

Journal Articles

Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents

Caroline Diorio, Laura Hernandez-Miyares, Diego A. Espinoza, Brenda L. Banwell, Amit Bar-Or, Amanda M. DiNofia, Allison Barz Leahy, Zachary Martinez, Regina M. Myers, Sarah E. Hopkins, Susan R. Rheingold, David T. Teachey, Angela N. Viaene, Lisa M. Wray, Shannon L. Maude, Stephan A. Grupp, Jennifer L. McGuire

Blood (2024) 144 (13): 1387–1398.

https://doi.org/10.1182/blood.2024023933

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma

Holly Lee, Michael A. Durante, Sheri Skerget, Deeksha Vishwamitra, Sacha Benaoudia, Sungwoo Ahn, Mansour Poorebrahim, Elie Barakat, David Jung, Noémie Leblay, Bachisio Ziccheddu, Benjamin T. Diamond, Marios Papadimitriou, Adam D. Cohen, Ola Landgren, Paola Neri, Francesco Maura, Nizar J. Bahlis

Blood blood.2024026212.

https://doi.org/10.1182/blood.2024026212

Published: 2024

Includes: Supplemental data

Journal Articles

The present and future for CAR-T cell therapy in adult B-cell ALL

Claire Roddie, Alexandros Rampotas

Blood blood.2023022922.

https://doi.org/10.1182/blood.2023022922

Published: 2024

Journal Articles

NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma

Eve Blanquart, Rüçhan Ekren, Bineta Rigaud, Marie-Véronique Joubert, Virginie Baylot, Hélène Daunes, Marine Cuisinier, Marine Villard, Nadège Carrié, Céline Mazzotti, Liliana E. Lucca, Aurore Perrot, Jill Corre, Thierry Walzer, Hervé Avet-Loiseau, Pierre-Paul Axisa, Ludovic Martinet

Blood (2024) 144 (12): 1271–1283.

https://doi.org/10.1182/blood.2023023529

Published: 2024

Includes: Supplemental data

NARROW

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML

Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia

Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma

Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy

New insights into the biology of T-cell lymphomas

Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia

Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series

T-Cell Lymphomas in Recipients of CAR-T Cells: Assessing Risks and Causalities

Mitigation of checkpoint inhibitor–induced autoimmune hemolytic anemia through modulation of purinergic signaling

The intestinal microbiota and cellular therapy: implications for impact and mechanisms

Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases

Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents

Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma

The present and future for CAR-T cell therapy in adult B-cell ALL

NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only